Skip to main content
SpringerLink
Log in
Book cover

Adjuvant Therapy for Breast Cancer pp 317–328Cite as

Adjuvant Therapy in Patients with Breast Cancer During Pregnancy

  • Chapter
  • First Online:

Part of the book series: Cancer Treatment and Research ((CTAR,volume 151))

Abstract

Breast cancer is one of the most commonly diagnosed cancers during pregnancy accounting for 1/3,000 pregnancies. It is believed that the incidence of breast cancer during pregnancy (BCP) will increase as more women delay child-bearing and because the incidence of breast cancer increases with increasing age.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Parente JT, Amsel M, Lerner R, Chinea F. Breast cancer associated with pregnancy. Obstet Gynecol. 1988;71:861–4.

    PubMed  CAS  Google Scholar 

  2. Tobon H, Horowitz LF. Breast cancer during pregnancy. Breast Dis. 1993;6:127–34.

    Google Scholar 

  3. King RM, Welch JS, Martin JK Jr, Coulam CB. Carcinoma of the breast associated with pregnancy. Surg Gynecol Obstet. 1985;160:228–32.

    PubMed  CAS  Google Scholar 

  4. Fisher CJ, Egan MK, Smith P, Wicks K, Millis RR, Fentiman IS. Histopathology of breast cancer in relation to age. Br J Cancer. 1997;75:593–6.

    Article  PubMed  CAS  Google Scholar 

  5. Shousha S. Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med. 2000;124:1053–60.

    PubMed  CAS  Google Scholar 

  6. Ishida T, Yokoe T, Kasmu F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: Analysis of case-control study in Japan. Jpn J Cancer Res. 1992;83:1143–9.

    Article  PubMed  CAS  Google Scholar 

  7. Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A. Breast carcinoma in pregnant women: Assessment of clinicopathologic and immunohistochemical features. Cancer. 2003;98;1055–60.

    Article  PubMed  Google Scholar 

  8. Maru D, Middleton LP, Wang S, Valero V, Sahin A. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger. Cancer. 2005;103:900–5.

    Article  PubMed  CAS  Google Scholar 

  9. Elledge RM, Ciocca DR, Langone G, McGuire WL. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer. 1993;71:2499–506.

    Article  PubMed  CAS  Google Scholar 

  10. Lebeau A, Deimling D, Kaltz C, Sendelhofert A, Iff A, Luthardt B, et al. Her-2/neu analysis in archival tissue samples of human breast cancer: Comparison of immunohistochemistry and fluorescence in situ hybridization. J Clin Oncol. 2001;19: 354–63.

    PubMed  CAS  Google Scholar 

  11. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, Buzdar AU, Hortobagyi GN. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17:855–61.

    PubMed  CAS  Google Scholar 

  12. Hahn K, Johnson PE, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyyi GN, Theriault RL. Treatment of pregnant breast cancer patients and outcomes of children exposed to vhemotherapy in utero. Cancer 2006;upub ahead of print

    Google Scholar 

  13. Kalter H, Warkany J. Congenital malformations. N Engl J Med. 1983;308:424–31,491–7.

    Article  PubMed  CAS  Google Scholar 

  14. Doll DC, Ringenberg QS. Yarbro JW. Antineoplastic Agents in Pregnancy. Sem Oncol. 1989;16:337–46.

    CAS  Google Scholar 

  15. Ebert U, Löffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther. 1997;74:207–20.

    Article  PubMed  CAS  Google Scholar 

  16. Woo JC, Yu T, Hurd TC. Breast Cancer in pregnancy: A literature review. Arch Surg. 2003;138:91–8.

    Article  PubMed  Google Scholar 

  17. Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy: A French national survey. Cancer. 1999;86:2266–72.

    Article  PubMed  CAS  Google Scholar 

  18. Warkany J. Aminopterin and methotrexate: Folic acid deficiency. Teratology. 1978;17:353–7.

    Article  PubMed  CAS  Google Scholar 

  19. Feldkamp M, Carey JC. Clinical teratology counseling and consultation case report: Low dose methotrexate exposure in the early weeks of pregnancy. Teratology. 1993;47:533–9.

    Article  PubMed  CAS  Google Scholar 

  20. Maghfoor I, Doll DC. Chemotherapy in pregnancy. In: Perry MC, ed. The chemotherapy source book. 3rd ed. 537–46.

    Google Scholar 

  21. Glantz JC. Reproductive toxicology of alkylating agents. Obstet Gynecol Surv. 1994;49:709–15.

    Article  PubMed  CAS  Google Scholar 

  22. Garcia V, Miguel JS, Borrasca AL. Doxorubicin in the first trimester of pregnancy. Ann Intern Med. 1981;94:547.

    PubMed  CAS  Google Scholar 

  23. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: Embryo-fetal outcome in 160 patients. Ann Oncol. 2004;15:146–50.

    Article  PubMed  CAS  Google Scholar 

  24. De Santis M, Lucchese A, De Carolis S, Ferrazani S, Caruso A. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care. 2000;9:235–7.

    Article  Google Scholar 

  25. Gadducci A, Cosio S, Fanucchi A, et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: Case report and review of the literature. Anticancer Res. 2003;23:5225–9.

    PubMed  Google Scholar 

  26. Gonzalez-Angulo AM, Walters RS, Carpenter RJ, et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer. 2004;5:317–9.

    Article  PubMed  Google Scholar 

  27. Nieto Y, Santiseban M, Aramendia JM, Fernandez-Hidalgo O, Garcia-Manerom, Lopez G. Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer. 2006;6:533–4.

    Article  PubMed  Google Scholar 

  28. Little BB. Pharmacokinetics during pregnancy: Evidence-based maternal dose formulation. Obstet Gynecol. 1999;93:658–68.

    Article  Google Scholar 

  29. Mucklow JC. The fate of drugs in pregnancy. Clin Obstet Gynecol. 1986;13:161–75.

    CAS  Google Scholar 

  30. Arceci RJ, Croop JM, Horwitz SB, Housman D. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci U S A. 1988;85:4350–4.

    Article  PubMed  CAS  Google Scholar 

  31. Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, Schinkel AH. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest. 1999;104:1441–7.

    Article  PubMed  CAS  Google Scholar 

  32. Gedeon C, Koren G. Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta. 2006;27:861–8.

    Article  PubMed  CAS  Google Scholar 

  33. Evseenko DA, Paxton JW, Keelan JA. ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Intergr Comp Physiol. 2006;290:R1357–65.

    Article  CAS  Google Scholar 

  34. Aviles A, Neri N. Hematological Malignancies and Pregnancy: A Final Report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2:173–7.

    Article  PubMed  CAS  Google Scholar 

  35. Kremer LC, van Dalen EC, Offringa M, Ottenkamp J, Voute PA. Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study. J Clin Oncol. 2001;19:191–6.

    PubMed  CAS  Google Scholar 

  36. Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voute PA. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: A systematic review. Ann Oncol. 2002;13:819–29.

    Article  PubMed  CAS  Google Scholar 

  37. Kremer LC, van Dalen EC, Offringa M, Voute PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: A systematic review. Ann Oncol. 2002;13:503–12

    Article  PubMed  CAS  Google Scholar 

  38. Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: Case report and review of the literature. Ultrasound Obstet and Gynecol. 2001;18:62–6.

    Article  CAS  Google Scholar 

  39. Cunha GR, Taguchi O, Namikawa R, Nishizuka Y, Robboy SJ. Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. Hum Pathol. 1987;18:1132–43.

    Article  PubMed  CAS  Google Scholar 

  40. Oksuzoglu B, Guler N. An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol. 2002;104:79.

    Article  PubMed  Google Scholar 

  41. Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy-case report and literature review. Gynecologic Oncology. 2001;80:405–8.

    Article  PubMed  CAS  Google Scholar 

  42. Cullins SL, Pridjian G, Sutherland CM. Goldenhar's syndrome associated with tamoxifen given to the mother during gestation. JAMA. 1994;271:1905–6.

    Article  PubMed  CAS  Google Scholar 

  43. Tewari K, Bonebrake RG, Asrat T, Shanberg AM. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet. 1997;350:183.

    Article  PubMed  CAS  Google Scholar 

  44. Watson WJ. Herceptin (trastuzumab) therapy during pregnancy: Association with reversible anhydramnios. Obstet Gynecol. 2005;105:642–3.

    Article  PubMed  Google Scholar 

  45. Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast cancer. 2005;6:354–6.

    Article  PubMed  CAS  Google Scholar 

  46. Waterston AM, Graham J. Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol. 2006;24:321–2.

    Article  PubMed  Google Scholar 

  47. Culbert EC, Schfirin BS. Malignant hypercalcemia in pregnancy: Effect of pamidroinate on uterine contractions. Obstet Gynecol. 2006;108:789–91.

    Article  PubMed  Google Scholar 

  48. Illidge TM, Hussey M, Godden CW. Malignant hypercalcemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol. 1996;8:257–8.

    Article  CAS  Google Scholar 

  49. Bsat FA, Hoffman DE, Seubert DE. Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. J Perinatol. 2003;23:531–5.

    Article  PubMed  CAS  Google Scholar 

  50. Mahajan MK, Singh V. Assessment of efficacy of pyridoxine in control of radiation induced sickness. J Indian Med Assoc. 1998;96:82–3.

    PubMed  CAS  Google Scholar 

  51. Sahakian V, Rouse D, Sipes S, Rose N, Niebyl J. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: A randomized, double-blind placebo-controlled study. Obstet Gynecol. 1991;78:33–36.

    PubMed  CAS  Google Scholar 

  52. Rodriguez-Pinilla E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: A case-control study. Teratology. 1998;58:2–5.

    Article  PubMed  CAS  Google Scholar 

  53. Magee LA, Mazzotta P, Koren G. Evidence based view of safety and effectiveness of phamarcologic therapy for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002;186:256–61.

    Article  Google Scholar 

  54. Tincello DG, Johnstone MJ. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgrad Med J. 1996;72:688–9.

    Article  PubMed  CAS  Google Scholar 

  55. Sullivan CA, Johnson CA, Roach H, Martin RW, Stewart DK, Morrison JC. A pilot study of intravenous ondansetron for hyperemesis gravidarum. Am J Obstet Gynecol. 1996;174:1565–8.

    Article  PubMed  CAS  Google Scholar 

  56. Briggs GC, Freeman RK, Yaffee SM. A reference guide to fetal and neonatal risk: Drugs in pregnancy and lactation. Philadelphia (PA): Lippincott Williams & Wilkins; 1998.

    Google Scholar 

  57. Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, et al. American Society of Clinical Oncology. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol. 2000;18:3558–85.

    PubMed  CAS  Google Scholar 

  58. Medlock ES, Kaplan DL, Cecchini M, Ulich TR, Del Castilo J, Anderson J. Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis. Blood. 1993;81:916–22.

    PubMed  CAS  Google Scholar 

  59. Scott LL, Ramin SM, Richey M, Hanson J, Gilstrap LC. Erythropoietin use in pregnancy: Two cases and a review of the literature. Am J Perinatol. 1995;12:22–24.

    Article  PubMed  CAS  Google Scholar 

  60. Sifakis S, Angelakis E, Vardaki E, Koumantaki Y, Matalliotakis I, Koumantakis E. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecol Obstet Invest. 2001;51:150–6.

    Article  PubMed  CAS  Google Scholar 

  61. FDA. Federal Register. 1980;44:37434–67.

    Google Scholar 

  62. Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, Keller M, Harder S, Theriault RL, Crivellari D, Klingebiel T, Louwen F, Kaufmann M. Breast Cancer During Pregnancy. Cancer. 2006;106:237–46.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Research, Ambulantes Krebszentrum Frankfurt, Germany, German Breast Group, Neu-Isenburg, Germany

    Sibylle Loibl MD, PhD

Authors
  1. Sibylle Loibl MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sibylle Loibl MD, PhD .

Editor information

Editors and Affiliations

  1. Inselspital, Univ. Bern, Bern, 3010, Switzerland

    Monica Castiglione

  2. Inst. Jules Bordet, Universite Libre Bruxelles, Bd. de Waterloo 125, Bruxelles, 1000, Belgium

    Martine J. Piccart

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Loibl, S. (2009). Adjuvant Therapy in Patients with Breast Cancer During Pregnancy. In: Castiglione, M., Piccart, M. (eds) Adjuvant Therapy for Breast Cancer. Cancer Treatment and Research, vol 151. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75115-3_20

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-75115-3_20

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-75114-6

  • Online ISBN: 978-0-387-75115-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation